This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biondi, B. Articles by Cooper, D. S. Search for Related Content PubMed PubMed Citation Articles by Biondi, B. Articles by Cooper, D. S.

The Clinical Significance of Subclinical Thyroid Dysfunction

Department of Clinical and Molecular Endocrinology and Oncology (B.B.), University of Naples Federico II, 80131 Naples, Italy; and Sinai Hospital of Baltimore (D.S.C.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215

Correspondence: Address all correspondence and requests for reprints to: Bernadette Biondi, Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. E-mail: bebiondi{at}unina.it or bebiondi{at}libero.it

Subclinical thyroid disease (SCTD) is defined as serum free T₄ and free T₃ levels within their respective reference ranges in the presence of abnormal serum TSH levels. SCTD is being diagnosed more frequently in clinical practice in young and middle-aged people as well as in the elderly. However, the clinical significance of subclinical thyroid dysfunction is much debated. Subclinical hyper- and hypothyroidism can have repercussions on the cardiovascular system and bone, as well as on other organs and systems. However, the treatment and management of SCTD and population screening are controversial despite the potential risk of progression to overt disease, and there is no consensus on the thyroid hormone and thyrotropin cutoff values at which treatment should be contemplated. Opinions differ regarding tissue effects, symptoms, signs, and cardiovascular risk. Here, we critically review the data on the prevalence and progression of SCTD, its tissue effects, and its prognostic implications. We also examine the mechanisms underlying tissue alterations in SCTD and the effects of replacement therapy on progression and tissue parameters. Lastly, we address the issue of the need to treat slight thyroid hormone deficiency or excess in relation to the patient’s age.

This article has been cited by other articles:

				R. J Levine, L. J Vatten, G. L Horowitz, C. Qian, P. R Romundstad, K. F Yu, A. N Hollenberg, A. I Hellevik, B. O Asvold, and S A. Karumanchi Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study BMJ, November 17, 2009; 339(nov17_1): b4336 - b4336. [Abstract] [Full Text] [PDF]

				A. Nicoletti, M. Bal, G. De Marco, L. Baldazzi, P. Agretti, S. Menabo, E. Ballarini, A. Cicognani, M. Tonacchera, and A. Cassio Thyrotropin-Stimulating Hormone Receptor Gene Analysis in Pediatric Patients with Non-Autoimmune Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4187 - 4194. [Abstract] [Full Text] [PDF]

				H. A. Ross, M. den Heijer, A. R.M.M. Hermus, and F. C.G.J. Sweep Composite Reference Interval for Thyroid-Stimulating Hormone and Free Thyroxine, Comparison with Common Cutoff Values, and Reconsideration of Subclinical Thyroid Disease Clin. Chem., November 1, 2009; 55(11): 2019 - 2025. [Abstract] [Full Text] [PDF]

				N. Correia, S. Mullally, G. Cooke, T. K. Tun, N. Phelan, J. Feeney, M. Fitzgibbon, G. Boran, S. O'Mara, and J. Gibney Evidence for a Specific Defect in Hippocampal Memory in Overt and Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3789 - 3797. [Abstract] [Full Text] [PDF]

				T.-G. Bach-Huynh, B. Nayak, J. Loh, S. Soldin, and J. Jonklaas Timing of Levothyroxine Administration Affects Serum Thyrotropin Concentration J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3905 - 3912. [Abstract] [Full Text] [PDF]

				E. M. Kaptein, E. Beale, and L. S. Chan Thyroid Hormone Therapy for Obesity and Nonthyroidal Illnesses: A Systematic Review J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3663 - 3675. [Abstract] [Full Text] [PDF]

				M. Alevizaki, K. Saltiki, P. Voidonikola, E. Mantzou, C. Papamichael, and K. Stamatelopoulos Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals Eur. J. Endocrinol., September 1, 2009; 161(3): 459 - 465. [Abstract] [Full Text] [PDF]

				S. Goldman, M. McCarren, E. Morkin, P. W. Ladenson, R. Edson, S. Warren, J. Ohm, H. Thai, L. Churby, J. Barnhill, et al. DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial Veterans Affairs Cooperative Study Circulation, June 23, 2009; 119(24): 3093 - 3100. [Abstract] [Full Text] [PDF]

				Y. J. Park, J. W. Yoon, K. I. Kim, Y. J. Lee, K. W. Kim, S. H. Choi, S. Lim, D. J. Choi, K.-H. Park, J. H. Choh, et al. Subclinical Hypothyroidism Might Increase the Risk of Transient Atrial Fibrillation After Coronary Artery Bypass Grafting. Ann. Thorac. Surg., June 1, 2009; 87(6): 1846 - 1852. [Abstract] [Full Text] [PDF]

				M. B. Zimmermann Iodine Deficiency Endocr. Rev., June 1, 2009; 30(4): 376 - 408. [Abstract] [Full Text] [PDF]

				L. Lazar, R. B.-D. Frumkin, E. Battat, Y. Lebenthal, M. Phillip, and J. Meyerovitch Natural History of Thyroid Function Tests over 5 Years in a Large Pediatric Cohort J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1678 - 1682. [Abstract] [Full Text] [PDF]

				G. Atzmon, N. Barzilai, J. G. Hollowell, M. I. Surks, and I. Gabriely Extreme Longevity Is Associated with Increased Serum Thyrotropin J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1251 - 1254. [Abstract] [Full Text] [PDF]

				M. Rotondi, P. Leporati, A. La Manna, B. Pirali, T. Mondello, R. Fonte, F. Magri, and L. Chiovato Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur. J. Endocrinol., March 1, 2009; 160(3): 403 - 408. [Abstract] [Full Text] [PDF]

				T. Ventura, R. Manor, E. D. Aflalo, S. Weil, S. Raviv, L. Glazer, and A. Sagi Temporal Silencing of an Androgenic Gland-Specific Insulin-Like Gene Affecting Phenotypical Gender Differences and Spermatogenesis Endocrinology, March 1, 2009; 150(3): 1278 - 1286. [Abstract] [Full Text] [PDF]

				B. Goichot, R. Sapin, and J. L. Schlienger Subclinical Hyperthyroidism: Considerations in Defining the Lower Limit of the Thyrotropin Reference Interval Clin. Chem., March 1, 2009; 55(3): 420 - 424. [Abstract] [Full Text] [PDF]

				V. Fatourechi Subclinical Hypothyroidism: An Update for Primary Care Physicians Mayo Clin. Proc., January 1, 2009; 84(1): 65 - 71. [Abstract] [Full Text] [PDF]

				H. Kumar K. V. S., A. Verma, J. Muthukrishnan, and K. D. Modi Obesity and Hypothyroidism: Symbiotic Coexistence Arch Intern Med, October 27, 2008; 168(19): 2168 - 2168. [Full Text] [PDF]

				B. Biondi Should we treat all subjects with subclinical thyroid disease the same way? Eur. J. Endocrinol., September 1, 2008; 159(3): 343 - 345. [Full Text] [PDF]

				M. Chonchol, G. Lippi, G. Salvagno, G. Zoppini, M. Muggeo, and G. Targher Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1296 - 1300. [Abstract] [Full Text] [PDF]

				S. Mariotti Mild Hypothyroidism and Ischemic Heart Disease: Is Age the Answer? J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2969 - 2971. [Full Text] [PDF]

				S. Razvi, A. Shakoor, M. Vanderpump, J. U. Weaver, and S. H. S. Pearce The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2998 - 3007. [Abstract] [Full Text] [PDF]